peritoneal cavity
腹膜腔
peritoneal dialysis
腹膜透析
peritoneal fluid
腹膜液
peritoneal membrane
腹膜膜
peritoneal cancer
腹膜癌
Objective To evaluate the incidence of depress in hemodia lysis and peritoneal dialysis uremia patients.
目的 評價進行血液透析和腹膜透析治療的尿毒症患 者抑鬱症的發病情況。
Conclusion： The monocaryon - macrophage toxic action in peritoneal fluid was down obviously in duration of pregnancy placental infection by MCMV.
結論：孕期胎盤MCMV感染明顯降低孕鼠腹腔液中單核-巨噬細胞胞毒作用。
Conclusion It is shown that fructosamine and AGEs were significantly higher in patients on CAPD,and they could not be effectively removed by peritoneal dialysis.
結論 提示糖化產物在腹膜透析患者體內增多，腹膜透析清除效果差，且可能影響腹膜轉運功能。
Peritoneal lavage,poly-tube drainge, omental bursa incision, pancreatic envelope and pancreatic bed brisement were made mainly.
結果:臨牀療效滿意,治癒7例,1例死於ARDS。
The results provided clinical basis for cisplatin isotone peritoneal chemotherapy as well as established a method for the research of drug release, absorbed dose and absortive rate.
其結呆不僅給臨牀順鉑腹腔化療提供理論依據而且提出研究體內藥物釋放，藥物吸收量及藥物吸收速率的方法。
At present, all over the world, about one hundred thousand uraemic patients, which is about 15 precent of the total dialysis population are accepting peritoneal dialysis treatment.
腹膜透析是通過腹膜這層天然的生物膜，腹腔中的腹透液和腹膜毛細血管內的血液之間進行水和溶質轉運與交換的過程。目前全世界約有10萬名終末期透析患者接受腹膜透析治療，約佔透析人口總數的15%。
peritoneal cavity
腹膜腔
peritoneal dialysis
腹膜透析
peritoneal fluid
腹膜液
peritoneal membrane
腹膜膜
peritoneal cancer
腹膜癌
Objective To evaluate the incidence of depress in hemodia lysis and peritoneal dialysis uremia patients.
目的 評價進行血液透析和腹膜透析治療的尿毒症患 者抑鬱症的發病情況。
Conclusion： The monocaryon - macrophage toxic action in peritoneal fluid was down obviously in duration of pregnancy placental infection by MCMV.
結論：孕期胎盤MCMV感染明顯降低孕鼠腹腔液中單核-巨噬細胞胞毒作用。
Conclusion It is shown that fructosamine and AGEs were significantly higher in patients on CAPD,and they could not be effectively removed by peritoneal dialysis.
結論 提示糖化產物在腹膜透析患者體內增多，腹膜透析清除效果差，且可能影響腹膜轉運功能。
Peritoneal lavage,poly-tube drainge, omental bursa incision, pancreatic envelope and pancreatic bed brisement were made mainly.
結果:臨牀療效滿意,治癒7例,1例死於ARDS。
The results provided clinical basis for cisplatin isotone peritoneal chemotherapy as well as established a method for the research of drug release, absorbed dose and absortive rate.
其結呆不僅給臨牀順鉑腹腔化療提供理論依據而且提出研究體內藥物釋放，藥物吸收量及藥物吸收速率的方法。
At present, all over the world, about one hundred thousand uraemic patients, which is about 15 precent of the total dialysis population are accepting peritoneal dialysis treatment.
腹膜透析是通過腹膜這層天然的生物膜，腹腔中的腹透液和腹膜毛細血管內的血液之間進行水和溶質轉運與交換的過程。目前全世界約有10萬名終末期透析患者接受腹膜透析治療，約佔透析人口總數的15%。
探索常見搜尋詞彙